5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.34▲ | 1.34▲ | 1.34▲ | 1.37▼ | 1.40▼ |
MA10 | 1.36▼ | 1.37▼ | 1.37▼ | 1.44▼ | 1.45▼ |
MA20 | 1.38▼ | 1.38▼ | 1.39▼ | 1.48▼ | 1.47▼ |
MA50 | 1.40▼ | 1.39▼ | 1.43▼ | 1.54▼ | N/A |
MA100 | 1.40▼ | 1.47▼ | 1.52▼ | 1.53▼ | N/A |
MA200 | 1.51▼ | 1.55▼ | 1.55▼ | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.007▼ | -0.006▼ | -0.004▼ | -0.015▼ | N/A |
RSI | 44.660▼ | 43.377▼ | 43.505▼ | 44.318▼ | 46.213▼ |
STOCH | 13.561▼ | 10.985▼ | 11.291▼ | 7.591▼ | 24.172 |
WILL %R | -77.273▼ | -88.095▼ | -88.095▼ | -96.563▼ | -81.184▼ |
CCI | -53.289 | -67.556 | -86.308 | -104.361▼ | -105.850▼ |
Tuesday, February 18, 2025 12:01 PM
Kairos Pharma (NYSE American: KAPA) announced that Cedars-Sinai Medical Center, through its academic partnership with the company, has received $600 ...
|
Tuesday, February 18, 2025 05:42 AM
Kairos Pharma (KAPA) announced that through its academic partnership with Cedars-Sinai Medical Center, Cedars-Sinai has received $600,000 in ...
|
Tuesday, February 18, 2025 05:30 AM
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announces that through its academic partnership with Cedars-Sinai Medical Center, Cedars-Sinai has received $600, ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
18/02/25 | 1.36 | 1.43 | 1.309 | 1.33 | 163,800 |
14/02/25 | 1.32 | 1.57 | 1.32 | 1.37 | 191,500 |
13/02/25 | 1.52 | 1.52 | 1.3606 | 1.45 | 171,159 |
12/02/25 | 1.35 | 1.45 | 1.32 | 1.36 | 157,152 |
11/02/25 | 1.43 | 1.48 | 1.35 | 1.35 | 175,800 |
10/02/25 | 1.38 | 1.44 | 1.35 | 1.37 | 122,100 |
07/02/25 | 1.44 | 1.4939 | 1.35 | 1.38 | 208,318 |
06/02/25 | 1.58 | 1.58 | 1.42 | 1.44 | 358,072 |
05/02/25 | 1.64 | 1.70 | 1.58 | 1.58 | 487,708 |
04/02/25 | 1.73 | 1.92 | 1.57 | 1.74 | 11,261,708 |
|
|
||||
|
|
||||
|
|